Glucagen and Dyspnea - a phase IV clinical study of FDA data

Summary:

Dyspnea is reported as a side effect among people who take Glucagen (glucagon hydrochloride recombinant), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Pantoprazole, and have Asthma.

The phase IV clinical study analyzes which people have Dyspnea when taking Glucagen. It is created by eHealthMe based on reports of 577 people who have side effects when taking Glucagen from the FDA, and is updated regularly.

What is Glucagen?

Glucagen has active ingredients of glucagon hydrochloride recombinant. eHealthMe is studying from 578 Glucagen users. Check the latest studies of Glucagen.

What is Dyspnea?

Dyspnea (difficult or laboured breathing) is found to be associated with 3,720 drugs and 6,067 conditions by eHealthMe. Check the latest studies of Dyspnea.

On Jul, 07, 2026

577 people reported to have side effects when taking Glucagen.
Among them, 46 people (7.97%) have Dyspnea.

Among these 46 people:

How long have people been on Glucagen when they have Dyspnea? *

What is the gender of people who have Dyspnea when taking Glucagen? *

female: 23.68 %
male: 76.32 %

What is the age of people who have Dyspnea when taking Glucagen? *

What are other drugs people take besides Glucagen? *

What are other side effects people have besides Dyspnea? *

Asthma: 32 people, 69.57%
Wheezing (a high-pitched whistling sound made while you breath): 31 people, 67.39%
Pain In Extremity: 31 people, 67.39%
Coughing Up Blood: 30 people, 65.22%
Neurological Symptom (symptoms of nervous system disease): 30 people, 65.22%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 30 people, 65.22%
Pulmonary Alveolar Haemorrhage (acute bleeding): 30 people, 65.22%
Pulmonary Vasculitis: 30 people, 65.22%
Lung Disorder (lung disease): 30 people, 65.22%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 30 people, 65.22%

What are the existing conditions these people have? *

Asthma: 9 people, 19.57%
Pain: 3 people, 6.52%
Muscle Spasms (muscle contraction): 2 people, 4.35%
Hypoglycemia (low blood sugar): 2 people, 4.35%
Type 1 Diabetes: 1 person, 2.17%
Hyperkalemia (damage to or disease of the kidney): 1 person, 2.17%
Abdominal Pain: 1 person, 2.17%
Abdominal Pain Upper: 1 person, 2.17%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 2.17%
Blood Pressure Abnormal: 1 person, 2.17%

* Approximation only. Some reports may have incomplete information.

Do you take Glucagen and have Dyspnea?

- Check whether Dyspnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glucagen:

Glucagen (578 reports)

Dyspnea treatments and more:

Dyspnea (661,578 reports)

How severe was Dyspnea and when was it recovered:

Dyspnea in Glucagen

Expand to all the drugs that have ingredients of glucagon hydrochloride recombinant:

Dyspnea and drugs with ingredients of glucagon hydrochloride recombinant

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glucagen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dyspnea:

Dyspnea (3,720 drugs)

Browse all the conditions that are associated with Dyspnea:

Dyspnea (6,067 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glucagon hydrochloride recombinant (the active ingredients of Glucagen) and Glucagen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.